Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series

Prognostic factors for elderly patients with primary malignant bone and soft tissue tumors

“…Previously, various factors associated with aging, including decreased performance status and the presence of significant comorbidities, have caused surgeons and medical oncologists to be cautious of using aggressive treatments for elderly patients with malignant tumors. This is due to the belief that an aggressive approach may have greater negative effects on these patients compared with on younger patients (24). However, with the development of multidisciplinary modalities, there are increased possibilities for aggressively treating elderly patients (25).…”

Epidemiology and Survival of Hepatocellular Carcinoma in North-east Peninsular Malaysia

“…The main treatments for HCC were hepatic resection, transcatheter arterial embolization, percutaneous ethanol injection therapy and regional chemotherapy (Takano et al 2000). There are many optional treatments available if HCC was diagnosed early.…”

Management of Hepatocellular Carcinoma

“…Though an initial treatment may prove successful, physicians must remain vigilant for disease recurrence and open to implementation of other treatment modalities as clinical circumstances change. Takano et al 160 described this approach in the treatment of 600 patients with HCC from a single Japanese institution. Although 54% of patients were treated with initial hepatic resection, recurrence was observed in 49% of those patients, and additional treatments included reresection, TACE, PEI, and regional chemotherapy.…”